Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Osteosarcoma: What chemo? When?
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Incidence and risk factors
Osteosarcoma (OSA) is the most common primary bone tumor in the dog (85% of skeletal malignancies). It is estimated to occur in over 8,000 dogs/year in the United States. OSA has bimodal age incidence peaks at 18-24 months and 7 years and occurs predominately in large to giant breed dogs in the appendicular skeleton at metaphyseal sites, whereas smaller breed dogs generally have their OSA in the axial skeleton. For appendicular OSA, the saying “Away from the elbow and close to the knee” is a good generalization; however, OSA can occur at sites such as distal tibia and others. In addition OSA is seen in the oral cavity (maxilla or mandibular), nasal cavity, ribs, digits and many other bony sites. The etiology of OSA is unknown but thought to be related to traumatic microfractures.
Pathology and behavior
OSA is a malignant mesenchymal tumor of primitive bone cells. The presence of extracellular matrix production of osteoid helps differentiate OSA from other bone sarcomas such as chondrosarcoma, lymphosarcoma, Hemangiosarcoma, and others. There are multiple histologic sub-classifications (osteoblastic, fibroblastic, chondroblastic, telangiectatic, etc.) for OSA; however, sub-classifications do not presently appear to be prognostic. OSA causes bone lysis, production of bone, or both; pathological fractures can occur. Less than 5% of dogs present with radiographically detectable pulmonary metastasis whereas > 90% have micrometastases at presentation.
History and clinical signs
Most dogs with OSA present for lameness and/or swelling at the local site if appendicular in origin. For non-appendicular OSA, the history and clinical signs are dependent on the specific site of origin.
Diagnosis
Local radiographs document soft tissue swelling, bone lysis, production of bone, or a combination of both. The differential diagnosis for OSA includes: Primary or secondary bone tumor, myeloma, lymphoma, and osteomyelitis. The definitive diagnosis of OSA requires bone biopsy. While most biopsies of cancer aim for the periphery of a lesion, bone biopsies should be taken from the center of the lesion and multiple biopsies should be performed. In addition, a full physical examination with close palpation of local lymph nodes (aspirate & examine if enlarged) is also recommended. For additional staging, three view thoracic radiographs are strongly recommended. The utility of additional staging diagnostics such as bone survey radiographs and/ or nuclear medicine bone scanning are somewhat controversial. A surgical staging system suggests most OSA are stage IIb (high-grade, extra-compartmental and no gross metastasis).
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Comments (0)
Ask the author
0 comments